Day: September 8, 2020

GOLETA, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, has engaged investor relations specialists MZ Group (MZ) to lead a comprehensive strategic investor relations and financial communications program across all key markets.MZ Group will work closely with Resonant management to develop and implement a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment community. The campaign will highlight Resonant’s immense opportunity to efficiently monetize the growth of 5G with its proprietary XBAR® RF Filter design and other unique solutions the Company enables with its ISN® software tools platform for the development...

 SOLO EVs Are Coming to the U.S. SoonVANCOUVER, British Columbia, Sept. 08, 2020 (GLOBE NEWSWIRE) — ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) (“ElectraMeccanica” or the “Company”), a designer and manufacturer of electric vehicles, today released the first photos and video footage of a behind-the-scenes look at current SOLO EV production vehicles on the assembly line. Completed vehicles are expected to hit U.S. market this fall. Last month ElectraMeccanica announced the commencement of production of the SOLO EV through its manufacturing partner and strategic investor, Zongshen Industrial Group (“Zongshen”). The Company has targeted late November/early December for initial deliveries to those on its pre-order list before ramping production to meet increasing demand. The first deliveries will be to early adopters/reservation...

Jacksonville, Florida, Sept. 08, 2020 (GLOBE NEWSWIRE) — Global Warming Solutions, Inc. (TICKER: GWSO) today announced that it will begin the process of uplisting to the OTCQB. With the completion of the filing of its required financial statements, the Company is now a step closer to become eligible to up list its stock to a senior exchange.“We have worked toward this for some time now, and our plans to up list demonstrates our commitment to our shareholders and in building a great company with great progress on the way. Our current and future shareholders should all be very pleased with this milestone development for the company,” stated Vladimir Vasilenko, CEO of Global Warming Solutions, Inc.The Company’s stock is trading on the OTC Markets under the “Current Information” tier of the OTC Pinks since...

MOUNTAIN VIEW, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020 at 1:30 p.m. ET.A live audio webcast of the presentation can be accessed through the Investors section of the Company’s website at www.ChemoCentryx.com. A replay of the webcast will be available on the Company’s website for two weeks following the live presentation.About ChemoCentryxChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally administered, targeted therapies....

MONMOUTH JUNCTION, N.J., Sept. 08, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, today announced that Lawrence Kenyon, President, CEO and CFO of Outlook Therapeutics, will present at two upcoming investor conferences in September.The following are the details for the conferences.H.C. Wainwright 22nd Annual Global Investment ConferenceEvent: Fireside Chat Discussion and Q&ADate and Time: Monday, September 14, 2020 at 4:30 PM EDTOppenheimer Fall Healthcare Life Sciences & MedTech SummitEvent: Fireside Chat Discussion and Q&ADate and Time: Monday, September 21, 2020 at 2:30 PM EDTIn addition to the presentations, management will also...

BELTSVILLE, Md., Sept. 08, 2020 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference on September 15th at 4:15 pm Eastern time.A live audio webcast will be available through the Investors section of the company’s website at www.nextcure.com. A replay of the webcast will be available approximately two hours after the event and archived on the website for 30 days.About NextCure, Inc.NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases....

PURCHASE, NY, Sept. 08, 2020 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that executives from the Company, together with executives of Livongo, will participate in the following upcoming investor conferences:Wells Fargo Securities Healthcare Conference on Thursday, September 10 at 8:00 a.m. EasternMorgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16 at 9:30 a.m. Eastern TimeA live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/.About Teladoc HealthTeladoc Health is transforming how people access and experience healthcare. Recognized as the world leader in virtual care, Teladoc Health directly delivers millions of medical visits across 175 countries each...

– PK and PD profiles of macimorelin for pediatric use were within the expected range and comparable to results observed in adults –– Data from this study support the choice of 1.0 mg/kg dose of macimorelin for validity testing in a Phase 3 trial, expected to commence in Q1 2021 –CHARLESTON, S.C., Sept. 08, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced the presentation of results from its first pediatric study of macimorelin as a growth hormone stimulation test for the evaluation of childhood-onset growth hormone deficiency (“CGHD”) at the 22nd European Congress of Endocrinology (e-ECE 2020), being held September 5-9, 2020.The data were presented...

MELBOURNE, Australia, Sept. 08, 2020 (GLOBE NEWSWIRE) — Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, has today announced positive efficacy data from a study of its induced pluripotent stem cell (iPSC)-derived Cymerus™ mesenchymal stem cells (MSCs) in a preclinical rodent model of idiopathic pulmonary fibrosis (IPF).     Key highlights:Efficacy demonstrated in preclinical rodent model of IPF, a disease which causes severe lung damage and leads to respiratory failureExisting treatments for IPF have limited efficacyTreatment with Cynata’s Cymerus MSCs led to statistically significant improvements in multiple harmful effects of IPF, including interstitial fibrosis, dynamic lung compliance and airway resistanceDr. Kilian Kelly, Cynata’s...

Company to focus expanded D&I efforts across key areas of colleagues, culture and communities with commitments to: Double U.S. Black representation in management by 2024Spend $1 billion annually with minority- and women-owned businesses by 2024Appoint Global Chief Diversity & Inclusion Officer CHICAGO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Mondelēz International, Inc. (NASDAQ:MDLZ) announced today a multi-year commitment focused on elevating its existing diversity and inclusion initiatives to make meaningful impacts in the area of racial equity economic empowerment around the world. The plan is designed to accelerate the company’s existing D&I efforts following extensive consultations between company leaders, colleagues and experts through listening forums and educational sessions focused on diversity, inclusion and belonging.“Mondelēz...